Cannabis smoking

Why 2019 Could be a Reality Check for Cannabis Companies in North America

Retrieved on: 
Thursday, April 11, 2019
Cannabis smoking, Cannabis, Psychoactive drugs, Entheogens, Euphoriants, Effects of cannabis, Legality of cannabis

PALM BEACH, Florida, April 11, 2019 /PRNewswire/ -- This year 2019will be the year of maturation and expansion for the cannabis industry.

Key Points: 
  • PALM BEACH, Florida, April 11, 2019 /PRNewswire/ -- This year 2019will be the year of maturation and expansion for the cannabis industry.
  • A recent article in Forbes echoed this optimism: "This new year bodes well for the cannabis industry.
  • There's excitement as we welcome new states into the cannabis fold and fervent hope that we'll see movement toward making cannabis fully legal at the federal level.
  • Up until now, cannabis has been a "rising tide lifts all the boats" kind of industry.

Industry Reports Target CBD Edibles to Lead Market's Growth and Quickly Rising Revenues

Retrieved on: 
Thursday, April 11, 2019
Herbalism, Medicinal plants, Medicine, Health sciences, Clinical medicine, Cannabis smoking, Entheogens, Euphoriants, Edible, Cannabis, Medical cannabis

An article in an industry publication said: "There are product categories that plod along slowly for many years before suddenly catching on.

Key Points: 
  • An article in an industry publication said: "There are product categories that plod along slowly for many years before suddenly catching on.
  • Then there is CBD Three years ago, CBD sales barely registered as a product category.
  • Forbes also chimed in on what can happen in the edibles market, in an article headlined: "Edibles Are The Next Big Thing For Pot Entrepreneurs."
  • The article said: "As more states legalize cannabis for recreational use, edibles will become a huge market for entrepreneurs.

iAnthus to Speak at GMP Securities Cannabis Conference, Jefferies Cannabis Summit and Benzinga Cannabis Capital Conference

Retrieved on: 
Thursday, April 11, 2019
Medicine, Herbalism, Medicinal plants, Health sciences, Cannabis, Cannabis smoking, Entheogens, Legality of cannabis, Medical cannabis

("iAnthus" or the "Company") (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to announce that its management will be speaking at three major upcoming conferences: GMP Securities' Cannabis Conference in Toronto, Jefferies Cannabis Summit in New York, and the Benzinga Cannabis Capital Conference in Toronto.

Key Points: 
  • ("iAnthus" or the "Company") (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to announce that its management will be speaking at three major upcoming conferences: GMP Securities' Cannabis Conference in Toronto, Jefferies Cannabis Summit in New York, and the Benzinga Cannabis Capital Conference in Toronto.
  • Hadley Ford, CEO, will speak at the conference and host 1-on-1 meetings.
  • Beth Stavola, Chief Strategy Officer, will appear on the "Cannabis Retail Panel" and host 1-on-1 meetings alongside Mr. Ford.
  • iAnthus Capital Holdings, Inc. owns and operates best-in-class licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry.

'The Whole Equation': UK Medicinal Cannabis Industry Group Expanding Its Mission to Accelerate Clinical Trials, Regulate CBD and Promote Clinical Education With New Members and Strengthening of Leadership Team

Retrieved on: 
Thursday, April 11, 2019
Herbalism, Medicinal plants, Medicine, Health sciences, Health, Cannabis, Cannabis smoking, Entheogens, Medical cannabis

This spring, the CMC is expanding beyond its original focus on policy, research and advocacy to accelerate clinical trials, shape future regulation of CBD products and promote clinical education.

Key Points: 
  • This spring, the CMC is expanding beyond its original focus on policy, research and advocacy to accelerate clinical trials, shape future regulation of CBD products and promote clinical education.
  • This will generate new learning, accelerate access to medicine for patients and critically advance market authorisation of cannabis-based medicinal products (CBMP).
  • The CMC has two distinctive plans; one for childhood epilepsy, another for all other non-paediatric potential deployments of cannabis.
  • Members of the CMC are all legal, fully-licensed companies operating in jurisdictions where cannabis for medicinal purposes is lawful.

Khiron Announces Partnership to Initiate the First Cannabis Clinical Research in Latin America and Expand Product Development to Address the Global Skincare Market

Retrieved on: 
Wednesday, April 10, 2019
Medicinal plants, Medicine, Herbalism, Entheogens, Euphoriants, Health sciences, Plants, Cannabis smoking, Medical cannabis, Cannabis

Pursuant to the terms of the agreement, Khiron and CDFLLA will establish a clinical research partnership focused on the effectiveness of medical cannabis for dermatological conditions.

Key Points: 
  • Pursuant to the terms of the agreement, Khiron and CDFLLA will establish a clinical research partnership focused on the effectiveness of medical cannabis for dermatological conditions.
  • Cannabis clinical trials performed by Khiron and CDFLLA will be the first such studies conducted in Latin America.
  • Dr. Edwin Bendek, Khiron Medical Director, Skincare, comments: "Khiron is proud to work closely with the Centro Dermatolgico Federico Lleras Acosta ("CDFLLA") to pioneer cannabis research in Latin America.
  • Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America.

Avenu Insights & Analytics Adds Talent to Cannabis Compliance Practice

Retrieved on: 
Wednesday, April 10, 2019
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Medicine, Plants, Clinical medicine

SACRAMENTO, Calif., April 10, 2019 /PRNewswire/ --CALIFORNIA CANNABIS CONTROL CONFERENCE -- Avenu Insights & Analytics (Avenu), has named Brad Rowe as the company's leader in helping jurisdictions manage the introduction and regulation of legal cannabis.

Key Points: 
  • SACRAMENTO, Calif., April 10, 2019 /PRNewswire/ --CALIFORNIA CANNABIS CONTROL CONFERENCE -- Avenu Insights & Analytics (Avenu), has named Brad Rowe as the company's leader in helping jurisdictions manage the introduction and regulation of legal cannabis.
  • Rowe is based in California at the company's MuniServices subsidiary and will participate in the April 10-11 Cannabis Control Conference .
  • "Brad is one of the pioneers in helping governments adjust to the increasing acceptance of legal cannabis usage," says Avenu CEO Paul Colangelo.
  • Avenu Insights & Analytics has a long history of helping state and local governments boost revenue, optimize operations, and deepen community trust.

Producers Having a Hard Time Keeping Up with Demands for Medical Marijuana in Some States

Retrieved on: 
Wednesday, April 10, 2019
Cannabis, Drugs in the United States, Drugs, Cannabis in the United States, Cannabis smoking, Entheogens, Cannabis in Oregon

And while state lawmakers in Rhode Island consider legalizing recreational weed, sales of medical marijuana have gone through the ceiling surpassing all expectations.

Key Points: 
  • And while state lawmakers in Rhode Island consider legalizing recreational weed, sales of medical marijuana have gone through the ceiling surpassing all expectations.
  • Based on the shifting attitudes towards legalization and growth in medical demand, marijuana focused companies have been realizing a significant lift.
  • According to published figures, RI's three medical marijuana dispensaries are on pace to sell about $56 million worth of medicinal pot in fiscal 2019.
  • Although recreational cannabis has been legalized in just 10 states and Washington, DC, patients can use marijuana medicinally in 33 states and Washington, DC.

Producers Having a Hard Time Keeping Up with Demands for Medical Marijuana in Some States

Retrieved on: 
Wednesday, April 10, 2019
Cannabis, Drugs in the United States, Drugs, Cannabis in the United States, Cannabis smoking, Entheogens, Cannabis in Oregon

And while state lawmakers in Rhode Island consider legalizing recreational weed, sales of medical marijuana have gone through the ceiling surpassing all expectations.

Key Points: 
  • And while state lawmakers in Rhode Island consider legalizing recreational weed, sales of medical marijuana have gone through the ceiling surpassing all expectations.
  • Based on the shifting attitudes towards legalization and growth in medical demand, marijuana focused companies have been realizing a significant lift.
  • According to published figures, RI's three medical marijuana dispensaries are on pace to sell about $56 million worth of medicinal pot in fiscal 2019.
  • Although recreational cannabis has been legalized in just 10 states and Washington, DC, patients can use marijuana medicinally in 33 states and Washington, DC.

Lifestyle Delivery Systems Inc.'s Subsidiary, CSPA Group, Inc., Signs a Lease Agreement for a 20,000 Square Foot Warehouse Facility

Retrieved on: 
Wednesday, April 10, 2019
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Medicine, Plants, Clinical medicine

The new facility will be used to expand the Company's transportation and distribution operations in Adelanto, California.

Key Points: 
  • The new facility will be used to expand the Company's transportation and distribution operations in Adelanto, California.
  • The company manufactures extracted oils and distillates, producing CannaStripsTMunder a license agreement with Lifestyle Delivery Systems Inc. a British Columbia company.
  • Developing isogenic seed strains and automated cultivation methods for the cannabis industry with Lifestyle Delivery Systems Inc., a British Columbia company.
  • About Lifestyle Delivery Systems Inc.
    Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California.

IONIC Brands Signs LOI to Acquire Licensed Cannabis Volatile Extraction and Manufacturing Assets of Kavry Managment LLC

Retrieved on: 
Wednesday, April 10, 2019
Euphoriants, Cannabis, Cannabis smoking, Entheogens, Medicine, Psychoactive drugs, Drugs

VANCOUVER, British Columbia, April 10, 2019 /PRNewswire/ -- IONIC Brands Corp., formerly Zara Resources Inc. (CSE: IONC) ("IONIC BRANDS" or the "Company") announces today that it has entered into a Letter of Intent ("LOI") to acquire licensed cannabis volatile extraction and manufacturing assets of Kavry Management LLC ("Kavry").

Key Points: 
  • VANCOUVER, British Columbia, April 10, 2019 /PRNewswire/ -- IONIC Brands Corp., formerly Zara Resources Inc. (CSE: IONC) ("IONIC BRANDS" or the "Company") announces today that it has entered into a Letter of Intent ("LOI") to acquire licensed cannabis volatile extraction and manufacturing assets of Kavry Management LLC ("Kavry").
  • The Company will acquire the existing facility, all inventory and equipment of the current licensed cannabis volatile extraction in Adelanto, California.
  • The volatile extraction is the most efficient and rapid way of extracting cannabis.
  • Chairman and CEO John Gorst states, "the licensed volatile extraction and manufacturing facility in California is a tremendous asset for IONIC Brands as it fits our strategic plan of vertical integration.